This compound is a polyacetylated pharmaceutical intermediate featuring a complex bicyclic core with multiple ether and ester functional groups. It is structurally identified as a synthetic building block for the manufacture of specialized active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1298086-18-6
2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoic acid
pharmaceutical intermediate
(S)-(-)-Trityl glycidyl ether
pharmaceutical intermediate
Pamoic acid
pharmaceutical intermediate
1-(4-Chlorobenzhydryl)piperazine
pharmaceutical intermediate
Ertugliflozin
pharmaceutical raw material
Ertugliflozin pidolate
pharmaceutical raw material
[(1R,2S,3S,4R,5S)-2,3,4-triacetyloxy-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6,8-dioxabicyclo[3.2.1]octan-1-yl]methyl acetate
LFZVLROKLDGLRV-KTBGKDHWSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)Cl